ClearPoint Neuro (CLPT) Cash & Current Investments (2011 - 2026)

ClearPoint Neuro has disclosed Cash & Current Investments across 16 years of filings, most recently posting $35.6 million for Q1 2026.

• Cash & Current Investments for Q1 2026 came in at $35.6 million, up 187.4% year-over-year; the trailing twelve-month figure through Mar 2026 was $35.6 million (up 187.4% YoY), and the FY2025 annual result was $45.9 million, up 128.43% from the prior year.
• Cash & Current Investments came in at $35.6 million for Q1 2026 at ClearPoint Neuro, down from $45.9 million in the prior quarter.
• In the past five years, Cash & Current Investments ranged from a high of $49.7 million in Q1 2022 to a low of $12.4 million in Q1 2025.
• The 5-year median for Cash & Current Investments is $35.4 million (2024), against an average of $33.1 million.
• Across the five-year window, Cash & Current Investments plunged 65.01% in 2025 and soared 187.4% in 2026, its largest moves.
• ClearPoint Neuro's Cash & Current Investments stood at $37.5 million in 2022, then sank by 38.32% to $23.1 million in 2023, then retreated by 13.12% to $20.1 million in 2024, then soared by 128.43% to $45.9 million in 2025, then slipped by 22.48% to $35.6 million in 2026.
• The last three Cash & Current Investments figures came in at $35.6 million (Q1 2026), $45.9 million (Q4 2025), and $38.2 million (Q3 2025), per Business Quant data.